Annals of Oncology · 2016 · 35 citations · 0 references
MedicineOncologyPharmacologyCancer PharmacologyMedical OncologyMetastasisMalignant NeoplasmsMelanoma PharmacotherapyMetastatic Disease TreatmentTargeted Cancer TherapyTargeted TherapyTyrosine Kinase InhibitorsAtezolizumab TherapyBraf V600 MutationsMelanoma ImmunotherapyMelanoma ProgressionMetastatic Melanoma TreatmentPreliminary Investigation